1.
Describe the clinical manifestations of SpA conditions to promptly differentiate and diagnose
2.
Apply the latest clinical evidence for IL-17 antagonists for the management of SpA conditions
3.
Develop strategies to optimize the shared decision-making efforts and collaboration across the multidisciplinary care team in the management of SpA conditions